These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Antiphospholipid antibodies: findings at arteriography. Provenzale JM; Barboriak DP; Allen NB; Ortel TL AJNR Am J Neuroradiol; 1998 Apr; 19(4):611-6. PubMed ID: 9576644 [TBL] [Abstract][Full Text] [Related]
7. [Neuropsychiatric involvement in systemic lupus erythematosus. Part 2: diagnostic and therapy]. Weiner SM; Otte A; Uhl M; Brink I; Schumacher M; Peter HH Med Klin (Munich); 2003 Feb; 98(2):79-90. PubMed ID: 12601532 [TBL] [Abstract][Full Text] [Related]
8. Dural sinus thrombosis and venous infarction associated with antiphospholipid antibodies: MR findings. Provenzale JM; Loganbill HA J Comput Assist Tomogr; 1994; 18(5):719-23. PubMed ID: 8089318 [TBL] [Abstract][Full Text] [Related]
9. Myocardial infarction as the presenting manifestation of systemic lupus erythematosus with antiphosphatidylserine antibodies. Jansen NL; Snell JR; Moy JN Ann Allergy Asthma Immunol; 1996 Mar; 76(3):266-8. PubMed ID: 8634882 [TBL] [Abstract][Full Text] [Related]
10. Cerebrovascular disease risk factors: neuroradiologic findings in patients with activated protein C resistance. Provenzale JM; Barboriak DP; Davey IC; Ortel TL Radiology; 1998 Apr; 207(1):85-9. PubMed ID: 9530303 [TBL] [Abstract][Full Text] [Related]
11. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus and antiphospholipid antibodies: effective treatment with plasma exchange and immunosuppression. Hess DC; Sethi K; Awad E J Rheumatol; 1992 Sep; 19(9):1474-8. PubMed ID: 1433020 [TBL] [Abstract][Full Text] [Related]
12. Brain MR findings in patients with systemic lupus erythematosus with and without antiphospholipid antibody syndrome. Kaichi Y; Kakeda S; Moriya J; Ohnari N; Saito K; Tanaka Y; Tatsugami F; Date S; Awai K; Korogi Y AJNR Am J Neuroradiol; 2014 Jan; 35(1):100-5. PubMed ID: 23886740 [TBL] [Abstract][Full Text] [Related]
14. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. Danowski A; de Azevedo MN; de Souza Papi JA; Petri M J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935 [TBL] [Abstract][Full Text] [Related]
15. Intracranial vessel wall lesions in patients with systematic lupus erythematosus. Ide S; Kakeda S; Miyata M; Iwata S; Ohkubo N; Nakayamada S; Futatsuya K; Watanabe K; Moriya J; Fujino Y; Tanaka Y; Korogi Y J Magn Reson Imaging; 2018 Nov; 48(5):1237-1246. PubMed ID: 29473985 [TBL] [Abstract][Full Text] [Related]
16. [Incidence of selected antiphospholipid antibodies in a group of patients with systemic lupus erythematosus]. Fojtík Z; Beránek M; Klabusay M; Korístek Z; Buliková A Vnitr Lek; 2004 Apr; 50(4):267-73. PubMed ID: 15214295 [TBL] [Abstract][Full Text] [Related]
17. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study. Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348 [TBL] [Abstract][Full Text] [Related]
18. [Renal and cerebral infarctions in a patient with systemic lupus erythematosus without antiphospholipid antibodies]. Suwabe H; Moriuchi J; Hoshina Y; Iwata Y; Ichikawa Y; Arimori S Ryumachi; 1993 Aug; 33(4):335-40. PubMed ID: 8235916 [TBL] [Abstract][Full Text] [Related]